ANAHEIM, Calif., Aug 6, 2019
Noul Co., Ltd., (Noul) a diagnostic start-up focused on point-of-care, morphology-based diagnostics platform showcased their upcoming Blood Cell Morphology Analyzer (BCMA) during the 71st American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (AACC 2019).
Noul showcased its main product, miLab™ diagnostic platform, and the smart consumable test cartridges for Blood Cell Morphology Analyzer (BCMA) and Malaria diagnostics during the three-day exhibition. Approximately 600 million cases of manual microscope tests are conducted globally in laboratories of all sizes. miLab™ automates the testing process, including the tedious sample slide preparation, enabling small to medium size laboratories with limited testing facilities to conduct morphology-based diagnosis for blood-related tests.
David Lim, CEO, and Co-Founder of Noul stated that miLab™ is expected to launch in the first half of 2020.